Presentation is loading. Please wait.

Presentation is loading. Please wait.

Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens.

Published byValerie Cobb Modified over 4 years ago

Similar presentations

Presentation on theme: "Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens."— Presentation transcript:

1 Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. (A) PT IgG; (B) PT IgA; (C) FHA IgG; (D) FHA IgA. Visit 1, antibody values for serum obtained at the time of diagnosis; visit 2, antibody values for serum obtained approximately 1 year after diagnosis; visit 3, antibody values for serum obtained approximately 2 years after diagnosis. Box-whisker plots represent boxes for medians with 25th and 75th percentiles and whiskers for 10th and 90th percentiles. Closed circles represent outliers. The numbers in each box chart represent the probability values obtained by Student's t test. Mineo Watanabe et al. Clin. Vaccine Immunol. 2006; doi: /CVI

Download ppt "Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens."

Similar presentations

Cumulative frequency Cumulative frequency graph

Cumulative frequency Cumulative frequency graph
Distribution of Zn isotopes during Alzheimer’s disease

Distribution of Zn isotopes during Alzheimer’s disease
A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.

A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.
Hospital-level variation in diagnostic testing for children with AGE evaluated in the ED and discharged from (A) or admitted to (B) the hospital. Hospital-level.

Hospital-level variation in diagnostic testing for children with AGE evaluated in the ED and discharged from (A) or admitted to (B) the hospital. Hospital-level.
Box-And-Whisker Plots

Box-And-Whisker Plots
Box and Whisker Plot of the Distribution of Perceived Stress Scores for TMD Controls and TMD CasesThe horizontal line within the box is the median value.

Box and Whisker Plot of the Distribution of Perceived Stress Scores for TMD Controls and TMD CasesThe horizontal line within the box is the median value.
FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)

FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Protection from influenza virus challenge.

Protection from influenza virus challenge.
FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.

FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.
Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.

Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Box plot showing the distribution of pH by sample type, including: median (midline); mean (◊); 25th and 75th percentiles (box); and the range, excluding.

Box plot showing the distribution of pH by sample type, including: median (midline); mean (◊); 25th and 75th percentiles (box); and the range, excluding.
IL-18; IL-18BP; and free, biologically active IL-18 levels in nonsevere versus severe dengue cases. IL-18; IL-18BP; and free, biologically active IL-18.

IL-18; IL-18BP; and free, biologically active IL-18 levels in nonsevere versus severe dengue cases. IL-18; IL-18BP; and free, biologically active IL-18.
DCs induce the proliferation of autologous T cells.

DCs induce the proliferation of autologous T cells.
Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.

Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.
CCL19 levels are elevated in Lyme disease cases with PTLDS

CCL19 levels are elevated in Lyme disease cases with PTLDS
Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.

Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.
(Upper) Levels of antibodies (ELISA OD values) reactive with each of 16 recombinant proteins of S. zooepidemicus strain NC78 in 1:200 dilutions of convalescent-phase.

(Upper) Levels of antibodies (ELISA OD values) reactive with each of 16 recombinant proteins of S. zooepidemicus strain NC78 in 1:200 dilutions of convalescent-phase.
Comparison of relative activity of Adjuplex and other commonly used adjuvants. Comparison of relative activity of Adjuplex and other commonly used adjuvants.

Comparison of relative activity of Adjuplex and other commonly used adjuvants. Comparison of relative activity of Adjuplex and other commonly used adjuvants.

Similar presentations

Ads by Google